A role for tumour necrosis factor-α, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome

被引:201
作者
Gersuk, GR
Beckham, C
Loken, MR
Kiener, P
Anderson, JE
Farrand, A
Troutt, AB
Ledbetter, JA
Deeg, HJ
机构
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98109 USA
[3] Bristol Myers Squibb, Seattle, WA USA
[4] Immunex Res & Dev Corp, Seattle, WA 98101 USA
[5] Hematologics, Seattle, WA USA
关键词
MDS; TNF Fas/Fas-L; haemopoiesis;
D O I
10.1046/j.1365-2141.1998.00933.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apoptosis of haemopoietic cells in the marrow of patients with myelodysplastic syndrome (MDS) has been suggested as a mechanism for peripheral cytopenias. We determined the expression of Fas (CD95), Fas-Ligand (Fas-L) and TNF-alpha factors known to be involved in apoptosis, in the marrow of 44 patients with MDS and characterized their functional relevance in in vitro assays of haemopoiesis. Multidimensional flow cytometry revealed phenotypically aberrant blasts as defined by orthogonal light scatter and CD45 expression in the marrow of 24/44 patients. Among those blasts Fas expression was increased on CD34-positive cells and on cells co-expressing HLA-DR. In addition, Fas-L was expressed on some CD34(+) cells of MDS patients but was never detected on CD34+ cells in normal marrow Fas and Fas-L mRNAs as well as mRNA for TNF-alpha, known to increase Fas expression in normal marrow were up-regulated in patients with MDS. TNF-alpha protein and sTNF-R1 levels in marrow plasma were higher in MDS patients than controls (P<0.002 and <0.003, respectively). However, results were dependent upon disease category: TNF-alpha levels were significantly higher in patients with refractory anaemia (RA) than in patients with RA with excess blasts (RAEB) or RAEB in transformation (RAEB-T) (P=0.043), Conversely, the proportion of Fas-L-positive cells was lowest in patients with RA (P=0.037). In marrow cultures. Fas-Ig, rhu-TNFR:Fc or anti-TNF-alpha antibody, by blocking Fas or TNF mediated signals, respectively, significantly increased the numbers of haemopoietic colonies compared to untreated cells (P<0.001, P<0.003, P<0.001, respectively). These results show significant dysregulation in the expression of TNF-alpha, Fas and Fas-L in the marrow from MDS patients. Altered expression of these molecules appears to be of functional relevance in the dysregulation of haemopoiesis in MDS and may be amenable to therapeutic interventions.
引用
收藏
页码:176 / 188
页数:13
相关论文
共 59 条
  • [1] FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    TOUGH, TW
    DAVISSMITH, T
    BRADDY, S
    FALK, B
    SCHOOLEY, KA
    GOODWIN, RG
    SMITH, CA
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 71 - 77
  • [2] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [3] Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
    Badley, AD
    McElhinny, JA
    Leibson, PJ
    Lynch, DH
    Alderson, MR
    Paya, CV
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 199 - 206
  • [4] POSITIVE SELECTION OF VIABLE CELL-POPULATIONS USING AVIDIN-BIOTIN IMMUNOADSORPTION
    BERENSON, RJ
    BENSINGER, WI
    KALAMASZ, D
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 91 (01) : 11 - 19
  • [5] Apoptosis in bone marrow of myelodysplastic syndrome patients
    Bogdanovic, AD
    Jankovic, GM
    Colovic, MD
    Trpinac, DP
    Bumbasirevic, VZ
    [J]. BLOOD, 1996, 87 (07) : 3064 - 3064
  • [6] Cascino I, 1996, J IMMUNOL, V156, P13
  • [7] CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO
    DEXTER, TM
    ALLEN, TD
    LAJTHA, LG
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) : 335 - 344
  • [8] AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95)
    DHEIN, J
    WALCZAK, H
    BAUMLER, C
    DEBATIN, KM
    KRAMMER, PH
    [J]. NATURE, 1995, 373 (6513) : 438 - 441
  • [9] THE ROLE OF GM-CSF, G-CSF, INTERLEUKIN-3, AND ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROMES
    GANSER, A
    SEIPELT, G
    HOELZER, D
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 : S34 - S39
  • [10] Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome
    Gersuk, GM
    Lee, JW
    Beckham, CA
    Anderson, J
    Deeg, HJ
    [J]. BLOOD, 1996, 88 (03) : 1122 - 1123